Elekta AB (publ)
EKTAY
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.97B
Close$
Share Statistics
| Market cap | $1.97 Billion |
|---|---|
| Enterprise Value | $13.46 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -7.48% |
|---|---|
| Return on Assets | -2.12% |
| Return on Invested Capital | 5.69% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.81 |
| Enterprise Value to EBIT | 19.32 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | 1.83 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Elekta AB
4,102 employees
CEO: Gustaf Salford Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology in...